The TSK Group was founded in 1948 by the original founder Yonesabura Kawashima, who later received the prestigious “Order of the Rising Sun” from emperor Akihito in 2011 for significant achievement and contribution to the nation for his work in the medical field.
His son Yukio Kawashima started TSK Laboratory, Japan in 1974. Shortly after founding his new company Mr Kawashima launched a very special kind of Biopsy needle, called SURECUT, invented by Mr. Yukio Kawashima. SURECUT was unique and offered physicians and the pathologists working with them a new tool in diagnosing Cancer and other diseases.
This meant more accurate diagnosis, better treatment, and lives saved. SURECUT became a market leading biopsy needle and over time was copied by many companies. Millions and Millions of these biopsy needles have been sold all over the world.
In the early 80’s TSK Laboratory introduced a new two-stage histological biopsy device called ACECUT. The advantages of that product have also improved diagnosis, and thereby allowing the appropriate treatment, which again, has saved millions of lives around the world.
Throughout the 1980-1990 TSK Laboratory several new needle innovations would be added the line of medical devices. The first international office was openend in Vancouver Canada by Mr Kawashima’s son in law Mr Shane Johnson. After TSK Laboratory Europe was established in 2010, TSK began producing needle products for the Aesthetics market.